Trademark: 79144403
Word
NEOFORDEX
Status
Dead
Status Code
709
Status Date
Friday, November 26, 2021
Serial Number
79144403
Registration Number
4705767
Registration Date
Tuesday, March 24, 2015
Mark Type
4000
Filing Date
Friday, January 31, 2014
Published for Opposition
Tuesday, January 6, 2015
Cancellation Date
Friday, November 26, 2021

Trademark Owner History
THERAVIA - Original Registrant
LABORATOIRES C.T.R.S. - Owner At Publication

Classifications
5 Pharmaceutical and veterinary products for treating progression of chronic diseases, proliferative diseases, and for treating rheumatological diseases; pharmaceutical and veterinary products for treating oncological diseases, especially colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, particularly primary tumors; pharmaceutical and veterinary products for treating onco-haematological diseases, especially lymphomas, especially Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, especially multiple myeloma, and leukemia; pharmaceutical and veterinary products for treating haematological diseases, especially amyloses, and purpura, especially thrombocytopenic purpura; pills, capsules, tablets, and powders pertaining to healthy diet for use in treating oncological diseases; chemical preparations for medical and pharmaceutical use for treating progression of chronic diseases, proliferative disease, and for treating rheumatological diseases; chemical preparations for medical and pharmaceutical use for treating oncological diseases, especially colon cancer, rectum cancer, breast cancer, prostate cancer, pancreatic cancer, gastric cancer, thyroid cancer, larynx cancer, liver cancer, uterine cancer, cervical cancer, esophagus cancer, ovarian cancer, lung cancer, pleural cancer, oral cavity cancer, kidney cancer, bladder cancer, testicular cancer, melanoma, lymphatic cancer, hematopoietic cancer, carcinoma, sarcoma, nervous system cancer, particularly primary tumors; chemical preparations for medical and pharmaceutical use for treating onco-haematological diseases, especially lymphomas, especially Hodgkin's disease and non-Hodgkin lymphomas, lymphadenopathy, myeloma, especially multiple myeloma, and leukemia; chemical preparations for medical and pharmaceutical use for treating haematological diseases, especially amyloses, and purpura, especially thrombocytopenic purpura
NEO FORDEX

Trademark Events
Feb 12, 2024
Change Of Name/Address Rec'd From Ib
Oct 2, 2022
Total Invalidation Processed By The Ib
Sep 7, 2022
Total Invalidation Of Reg Ext Protection Sent To Ib
Sep 7, 2022
Invalidation Processed
Jul 26, 2022
Total Invalidation Of Reg Ext Protection Created
Nov 26, 2021
Cancelled Section 71
May 7, 2020
New Representative At Ib Received
Mar 24, 2020
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Nov 15, 2019
New Representative At Ib Received
Sep 18, 2015
Final Decision Transaction Processed By Ib
Jul 30, 2015
Final Disposition Notice Sent To Ib
Jul 30, 2015
Final Disposition Processed
Jun 24, 2015
Final Disposition Notice Created, To Be Sent To Ib
Jun 6, 2015
New Representative At Ib Received
Mar 24, 2015
Registered-Principal Register
Jan 6, 2015
Official Gazette Publication Confirmation E-Mailed
Jan 6, 2015
Published For Opposition
Jan 3, 2015
Notification Processed By Ib
Dec 17, 2014
Notification Of Possible Opposition Sent To Ib
Dec 17, 2014
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Dec 17, 2014
Notification Of Notice Of Publication E-Mailed
Dec 1, 2014
Law Office Publication Review Completed
Nov 22, 2014
Assigned To Lie
Nov 4, 2014
Approved For Pub - Principal Register
Nov 4, 2014
Examiner's Amendment Entered
Nov 4, 2014
Notification Of Examiners Amendment E-Mailed
Nov 4, 2014
Examiners Amendment E-Mailed
Nov 4, 2014
Examiners Amendment -Written
Nov 1, 2014
Teas/Email Correspondence Entered
Oct 31, 2014
Correspondence Received In Law Office
Oct 31, 2014
Teas Response To Office Action Received
May 23, 2014
Refusal Processed By Ib
May 2, 2014
Non-Final Action Mailed - Refusal Sent To Ib
May 2, 2014
Refusal Processed By Mpu
May 2, 2014
Non-Final Action (Ib Refusal) Prepared For Review
May 1, 2014
Non-Final Action Written
Apr 29, 2014
Assigned To Examiner
Apr 1, 2014
Application Filing Receipt Mailed
Mar 28, 2014
New Application Office Supplied Data Entered
Mar 27, 2014
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24